about
Aspirin resistance and diabetic angiopathy: back to the futurePreventing adverse obstetric outcomes in women with genetic thrombophiliaRecombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome.Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.Acquired haemophilia a in the elderly: case reports.Current and evolving features in the clinical management of haemophiliaDefinition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.Systematic reviews and meta-analyses for more profitable strategies in peripheral artery diseaseAssociation between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysisHaemophilia B: from molecular diagnosis to gene therapy.A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?Haemophilia A: molecular insights.Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia.The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical interventionDiabetes, vascular complications and antiplatelet therapy: open problems.HELLP syndrome and its relation with the antiphospholipid syndrome.Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature.Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand?Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.Hemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigations?Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis.Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.Adverse outcome in women with thrombophilia and bilateral uterine artery notches.Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy.Prenatal diagnosis of haemophilia: our experience of 44 cases.Denaturing HPLC procedure for factor IX gene scanning.
P50
Q28168451-1FA9239D-E7CA-40F2-8E8A-568CC8DF85ACQ28193486-7E5162E7-72D8-4289-808A-48D53408F572Q33374177-78F60421-570A-455D-989D-587DC53B9EC4Q33394731-3D08AFE2-E2BB-4515-9C64-3F21CA79556BQ33699716-AFD5CC1C-95D9-43F2-85BC-8736180FE5D1Q33708976-50EDEF7C-503D-43F1-8BD3-568D4E107756Q33709003-FA0DC2DF-B012-48BA-B193-CD8DA5FD9E53Q34576281-B29E663A-26A3-4F93-90CE-6D8B7A0B8BF0Q35067214-99E8B7A0-EA7A-4376-9177-58316A6AF508Q35127766-D458AD90-C462-4240-84A2-9C94CA163C49Q35176160-5348240F-3D83-467A-9361-868EFDA05A5AQ36793856-E3E55AB5-25FF-4CC3-9F97-6014EC9F5EECQ36862474-6AC7B7AA-845B-4773-8584-368D05FC2631Q37204021-1588280A-44EC-49E7-BA94-4050A9D362B6Q37216351-0C828975-5C3D-43F9-A2D5-A9C8D12F63ECQ37338975-8169FEDD-B1A1-46DC-8584-F0CC3406FD03Q37588912-51D0BEF2-96DF-4A02-9D68-DCAEB6C281B7Q37964836-C613E767-5702-4052-AF94-85CE881C3FCFQ37971350-2B7A09DC-1546-45CC-A193-691371E27A1FQ37984127-C0375C3F-399F-46F3-A27E-DB6EDA3223FEQ37991557-C744340A-478B-45B1-9D75-ECC148EBFFF0Q38136137-44BD85D0-8E11-455A-9E8E-C7BE1C5E243FQ38136977-6DE62B9E-C514-4EB7-980B-288A9FFEAC98Q38187808-D70BE8D2-D8E8-4ECA-B3F1-C5F2CF3C1A0DQ38387378-8DE787BA-6C78-4520-8A58-2D7AEF25D720Q38411096-1530A077-80E1-4ACE-90DD-71658867EE23Q38588576-90D16DEE-0E13-4028-BB5E-AAE2E85F8A00Q40913617-579F8EFD-6CFF-4DCE-B55D-5EB231A74C6EQ42236600-F3185C28-C3D8-42C8-B6EC-C04B31B9E049Q42258039-2F4A509F-6C08-4D89-A893-25483512CEA8Q42478892-562C23EE-7F95-4EE4-AFFA-F5ACDB9B4173Q42958772-0A7BF25A-ACA7-432C-B267-C0672D9DC065Q43218590-30902B0C-329B-4898-BC27-33044609603FQ43587450-9E703903-1DF4-4EFD-91F5-7F1BDE7B9592Q43807755-BF175E78-B17B-41DA-901E-EBC10F76174DQ43847066-D75D4979-C4DC-4812-B8D4-47D837C3FBEAQ43910406-55AB1911-8DC7-4EAF-95E0-1CBC384706FAQ44452159-AD74564A-77A4-40BF-A625-16B2268A8F5DQ45855317-02A85BE5-F7B6-4729-AE89-BA6490589A51Q45861835-C8A100C8-56EB-4A2A-AC6D-E7A9FEA4583F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Di Minno
@ast
Giovanni Di Minno
@en
Giovanni Di Minno
@es
Giovanni Di Minno
@nl
Giovanni Di Minno
@sl
type
label
Giovanni Di Minno
@ast
Giovanni Di Minno
@en
Giovanni Di Minno
@es
Giovanni Di Minno
@nl
Giovanni Di Minno
@sl
prefLabel
Giovanni Di Minno
@ast
Giovanni Di Minno
@en
Giovanni Di Minno
@es
Giovanni Di Minno
@nl
Giovanni Di Minno
@sl
P106
P1153
7005817839
P21
P31
P496
0000-0003-4235-7166